Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Allergy|April 5, 2021
High-dimensional analysis defines multicytokine T-cell subsets and supports a role for IL-21 in atopic dermatitisTali Czarnowicki, Hyun Je Kim, Axel P Villani, et al.
JAMA Dermatology|June 21, 2023
Hyperactivation of the JAK2/STAT5 Signaling Pathway and Evaluation of Baricitinib Treatment Among Patients With Eosinophilic CellulitisJohanna Morot, Ester Del Duca, Marine Chastagner, et al.
The British Journal of Dermatology|November 29, 2024
Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trialAlexa B Kimball, Falk G Bechara, Aysha Badat, et al.
Allergy|April 18, 2021
Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 responseAxel P Villani, Ana B Pavel, Jianni Wu, et al.
Dermatology and Therapy|May 23, 2026
Criteria for Hidradenitis Suppurativa Competence CentersAngelo V Marzano, Falk G Bechara, Vivian Y Shi, et al.
Lancet (London, England)|February 6, 2023
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trialsAlexa B Kimball, Gregor B E Jemec, Afsaneh Alavi, et al.
Pageof 2